Insider Trading May 6, 2026 04:51 PM

MasTec Director Robert Campbell Executes $1.25 Million Stock Sale Amid High Valuation

The transaction occurs as MasTec reports significant earnings beats and maintains a record backlog, despite analysts' conflicting views on valuation.

By Nina Shah MTZ

MasTec Inc. (NASDAQ: MTZ) director Robert Campbell has completed a series of stock sales totaling $1,251,000. According to recent regulatory filings, the transactions took place on May 4, 2026. Mr. Campbell disposed of a total of 3,000 shares of common stock through 14 distinct transactions, with each sale executed at a price of $417.00 per share.This insider activity comes at a time when MasTec's equity is trading near its 52-week high of $438, following a period of substantial growth where the stock surged more than 200% over the last year. Following this divestment, Mr. Campbell maintains a direct holding of 30,646 shares in the company.

MasTec Director Robert Campbell Executes $1.25 Million Stock Sale Amid High Valuation
MTZ

Key Points

  • MasTec reported strong Q1 2026 results with EPS of $1.39 against an expected $0.99 and revenue of $3.83 billion.
  • Director Robert Campbell sold 3,000 shares at $417 per share, totaling over $1.25 million.
  • Analysts have raised price targets ranging from $440 to $493, supported by a $20.3 billion backlog.

MasTec Inc. (NASDAQ: MTZ) director Robert Campbell has executed a series of stock sales totaling $1,251,000. Based on recent filings, these transactions were finalized on May 4, 2026. Mr. Campbell sold 3,000 shares of MasTec common stock through 14 separate transactions, each occurring at a price of $417.00 per share.

This insider movement follows a period of significant appreciation for the company's stock, which has climbed over 200% in the past year and is currently trading near its 52-week high of $438. From a valuation perspective, MasTec is currently trading at a price-to-earnings (P/E) ratio of 74. While some metrics suggest the stock may be overvalued relative to fair value estimates, it is worth noting that 11 analysts have recently moved their earnings forecasts upward.

Financial Performance and Analyst Outlook

The sale occurs against a backdrop of robust financial results for MasTec. In its first-quarter 2026 earnings report, the company delivered an earnings per share (EPS) of $1.39, which exceeded the forecasted figure of $0.99. Furthermore, revenue reached $3.83 billion, surpassing the expected $3.48 billion.

In response to these results, several financial institutions have adjusted their price targets for MTZ:

  • Stifel increased its target to $455, pointing toward strong segment revenue growth and better-than-anticipated Pipeline margins.
  • Jefferies raised its target to $493, citing a record backlog of $20.3 billion and upwardly revised guidance as signs of continued momentum.
  • Clear Street adjusted its target to $440, noting a 34% increase in revenue and 73% growth in adjusted EBITDA driven by Pipeline and broad sales trends.
  • TD Cowen raised its target to $445, focusing on the expansion of the company's backlog.

Key Market Insights

The recent activity highlights several critical points for the specialty infrastructure and utility services sectors:

  • Strong Operational Momentum: The combination of a $20.3 billion record backlog and significant revenue beats suggests high demand in MasTec's core operating segments.
  • Earnings Outperformance: The substantial beat in both EPS and revenue indicates strong execution relative to market expectations.
  • Market Sentiment Divergence: There is a notable gap between aggressive price target increases from analysts and valuation models that suggest the stock may be trading above its fair value.

Risks and Uncertainties

Investors should consider the following factors identified in the current market data:

  • Valuation Pressures: With a P/E ratio of 74, there is an inherent risk that the stock may be overvalued according to certain fair value assessments.
  • Price Volatility: Given the stock's recent 200% surge and its proximity to 52-week highs, the equity may face volatility as it seeks a long-term equilibrium.

Risks

  • Valuation risk: The stock is trading at a P/E of 74 and may be overvalued relative to fair value estimates.
  • Price correction risk: The stock has experienced extreme growth, surging over 200% in one year.

More from Insider Trading

Black Stone Minerals Executive Executes Unit Sale via Rule 10b5-1 Trading Plan May 6, 2026 Black Stone Minerals Executive Executes Rule 10b5-1 Unit Sale May 6, 2026 Black Stone Minerals Executive Executes Unit Sale Under Pre-Established Trading Plan May 6, 2026 Bank7 Corp. Executive Vice President Executes Common Stock Sale May 6, 2026 First Financial Bankshares Director Increases Stake via Insider Purchase May 6, 2026